These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 20540648)

  • 21. APVO210: A Bispecific Anti-CD86-IL-10 Fusion Protein (ADAPTIR™) to Induce Antigen-Specific T Regulatory Type 1 Cells.
    Pellerin L; Chen P; Gregori S; Hernandez-Hoyos G; Bacchetta R; Roncarolo MG
    Front Immunol; 2018; 9():881. PubMed ID: 29887861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deficiency in the frequency and function of Tr1 cells in IgAV and the possible role of IL-27.
    Pan L; Wang J; Liu J; Guo L; Yang S
    Rheumatology (Oxford); 2021 Jul; 60(7):3432-3442. PubMed ID: 33280050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of human leukocyte antigen-G in the induction of adaptive type 1 regulatory T cells.
    Gregori S; Magnani CF; Roncarolo MG
    Hum Immunol; 2009 Dec; 70(12):966-9. PubMed ID: 19664675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysfunction of IL-10-producing type 1 regulatory T cells and CD4(+)CD25(+) regulatory T cells in a mimic model of human multiple sclerosis in Cynomolgus monkeys.
    Ma A; Xiong Z; Hu Y; Qi S; Song L; Dun H; Zhang L; Lou D; Yang P; Zhao Z; Wang X; Zhang D; Daloze P; Chen H
    Int Immunopharmacol; 2009 May; 9(5):599-608. PubMed ID: 19539557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tr1 regulatory T cells induced by ConA pretreatment prevent mice from ConA-induced hepatitis.
    Ye F; Yan S; Xu L; Jiang Z; Liu N; Xiong S; Wang Y; Chu Y
    Immunol Lett; 2009 Feb; 122(2):198-207. PubMed ID: 19200442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Biology of T Regulatory Type 1 Cells and Their Therapeutic Application in Immune-Mediated Diseases.
    Roncarolo MG; Gregori S; Bacchetta R; Battaglia M; Gagliani N
    Immunity; 2018 Dec; 49(6):1004-1019. PubMed ID: 30566879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-10 Gene-Modified Dendritic Cell-Induced Type 1 Regulatory T Cells Induce Transplant-Tolerance and Impede Graft Versus Host Disease After Allogeneic Stem Cell Transplantation.
    Wan J; Huang F; Hao S; Hu W; Liu C; Zhang W; Deng X; Chen L; Ma L; Tao R
    Cell Physiol Biochem; 2017; 43(1):353-366. PubMed ID: 28869950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo.
    Sonderegger I; Kisielow J; Meier R; King C; Kopf M
    Eur J Immunol; 2008 Jul; 38(7):1833-8. PubMed ID: 18546146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Family of IL-10-secreting CD4+ T cells.
    Fujio K; Okamura T; Yamamoto K
    Adv Immunol; 2010; 105():99-130. PubMed ID: 20510731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinoic acid-induced autoantigen-specific type 1 regulatory T cells suppress autoimmunity.
    Raverdeau M; Christofi M; Malara A; Wilk MM; Misiak A; Kuffova L; Yu T; McGinley AM; Quinn SM; Massilamany C; Reddy J; Forrester JV; Mills KH
    EMBO Rep; 2019 May; 20(5):. PubMed ID: 30894405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eomesodermin-expressing type 1 regulatory (EOMES
    Geginat J; Vasco C; Gruarin P; Bonnal R; Rossetti G; Silvestri Y; Carelli E; Pulvirenti N; Scantamburlo M; Moschetti G; Clemente F; Grassi F; Monticelli S; Pagani M; Abrignani S
    Eur J Immunol; 2023 May; 53(5):e2149775. PubMed ID: 36653901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity.
    Kim WS; Kim H; Kwon KW; Im SH; Lee BR; Ha SJ; Shin SJ
    Oncotarget; 2016 Jun; 7(23):33765-82. PubMed ID: 27172902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD55 costimulation induces differentiation of a discrete T regulatory type 1 cell population with a stable phenotype.
    Sutavani RV; Bradley RG; Ramage JM; Jackson AM; Durrant LG; Spendlove I
    J Immunol; 2013 Dec; 191(12):5895-903. PubMed ID: 24198281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases.
    Leng RX; Pan HF; Tao JH; Ye DQ
    Expert Opin Ther Targets; 2011 Feb; 15(2):119-26. PubMed ID: 21073280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis.
    Astier AL; Meiffren G; Freeman S; Hafler DA
    J Clin Invest; 2006 Dec; 116(12):3252-7. PubMed ID: 17099776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blimp-1-Dependent IL-10 Production by Tr1 Cells Regulates TNF-Mediated Tissue Pathology.
    Montes de Oca M; Kumar R; de Labastida Rivera F; Amante FH; Sheel M; Faleiro RJ; Bunn PT; Best SE; Beattie L; Ng SS; Edwards CL; Muller W; Cretney E; Nutt SL; Smyth MJ; Haque A; Hill GR; Sundar S; Kallies A; Engwerda CR
    PLoS Pathog; 2016 Jan; 12(1):e1005398. PubMed ID: 26765224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effect of IL-22 and IL-28 in Induction of Type 1 Regulatory T (Tr1) Cells.
    Arasteh J; Ebtekar M; Pourpak Z; Pourfatollah AA; Hassan ZM; Kardar GA; Zare A; Saghafi S; Tabar Molla Hassan A
    Iran J Allergy Asthma Immunol; 2015 Apr; 14(2):158-67. PubMed ID: 25780882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation of functional autologous collagen-II specific IL-10 producing Tr1 cell clones from rheumatoid arthritis blood.
    Brun V; Neveu V; Pers YM; Fabre S; Quatannens B; Bastian H; Clerget-Chossat N; Jorgensen C; Foussat A
    Int Immunopharmacol; 2011 Aug; 11(8):1074-8. PubMed ID: 21406270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiation and Characterization of Tr1 Cells.
    Chihara N; Madi A; Karwacz K; Awasthi A; Kuchroo VK
    Curr Protoc Immunol; 2016 Apr; 113():3.27.1-3.27.10. PubMed ID: 27038462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Critical role of IRF1 and BATF in forming chromatin landscape during type 1 regulatory cell differentiation.
    Karwacz K; Miraldi ER; Pokrovskii M; Madi A; Yosef N; Wortman I; Chen X; Watters A; Carriero N; Awasthi A; Regev A; Bonneau R; Littman D; Kuchroo VK
    Nat Immunol; 2017 Apr; 18(4):412-421. PubMed ID: 28166218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.